Related Experiment Video
Updated: Feb 7, 2026

The Supraclavicular Fossa Ultrasound View for Central Venous Catheter Placement and Catheter Change Over Guidewire
Published on: December 23, 2014
The dangerous liaisons between central venous stents and catheters: a case report
Matteo Maria Masseroli1,2, Daniela Torzillo1, Antonio Gidaro1,3
1Internal Medicine, L. Sacco Hospital, ASST-fbf-sacco, Milano, Italy.
Insights
Placing central venous catheters within stents can cause thrombosis and fibroblastic sleeves, leading to recurrent Superior Vena Cava Syndrome. Alternative access or careful management is advised.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiology
Background:
- Endovascular stenting is standard for superior vena cava (SVC) obstruction.
- No guidelines exist for concurrent central venous catheters (CICCs) within stents.
- Malignant Superior Vena Cava Syndrome (SVCS) presents complex management challenges.
Abstract:
Endovascular stenting is the standard of care for superior vena cava (SVC) obstruction, providing rapid symptom relief and high technical success rates. However, no guidelines exist for the concurrent use of centrally inserted central catheters (CICCs) within stents or for optimal antithrombotic strategies. We report a case of a 69-year-old woman with malignant Superior Vena Cava Syndrome (SVCS) treated with a central venous stent (CVS) placement who subsequently required a jugular CICC for antibiotic therapy. Six days later, she developed recurrent edema. Imaging revealed extensive thrombosis involving the stent and adjacent veins, while ultrasound demonstrated a prominent fibroblastic sleeve (fibrin sheath) at the catheter entry site. Despite thrombo-aspiration and catheter removal, the sleeve persisted, exhibiting the characteristic "ghost sign." Additional kissing stents restored partial patency, and anticoagulation was resumed.This case underscores the potential risks of placing a CICC within a previously inserted CVS. The coexistence of thrombosis and a fibroblastic sleeve on the same catheter-reported here for the first time-suggests that these entities, although distinct, can occur together. It is plausible that the flow reduction caused by the fibroblastic sleeve may increase the risk of thrombus formation, thereby raising the likelihood of stent thrombosis and recurrent SVCS. Imaging revealed that a fibroblastic sleeve, recognizable by the "ghost sign," persisted even after catheter removal, underscoring the diagnostic and therapeutic challenges of distinguishing it from thrombosis. Current guidelines do not address this situation, and data are limited. Until more evidence is available, clinicians should consider alternative access options-such as Femorally Inserted Central Catheters (FICCs)-when CVS are present and manage anticoagulation carefully. Multidisciplinary teamwork and regular follow-up are essential to improve outcomes and prevent recurrence.
More Related Videos
Related Concept Videos
Measures of Central Tendency
The Central Dogma
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Venous Thrombosis I: Introduction
Data Reporting and Recording

